Natural Alternatives International Inc 最近的每股收益为 $, $ 的预期。
Natural Alternatives International Inc NAII 上一季度的收入表现如何?
Natural Alternatives International Inc 上一季度的收入为 $
Natural Alternatives International Inc 的收入预期是多少?
根据 位华尔街分析师的预测,Natural Alternatives International Inc 的收入预期范围从 $ 到 $
Natural Alternatives International Inc 的盈利质量评分是多少?
Natural Alternatives International Inc 的盈利质量评分为 B+/55.032772。该评分基于盈利能力、增长、现金生成与资本分配以及杠杆四个维度。
Natural Alternatives International Inc 何时发布财报?
Natural Alternatives International Inc 的下一份财报预计在 2026-08-18 发布
Natural Alternatives International Inc 的预期收益是多少?
根据华尔街分析师的预测,Natural Alternatives International Inc 的预期收益为 $
Natural Alternatives International Inc 是否超出收益预期?
Natural Alternatives International Inc 最近的收益为 $, 预期。
关键数据
前收盘价
$2.17
开盘价
$2.26
当日区间
$2.19 - $2.27
52周范围
$2.08 - $4.96
交易量
878
平均成交量
19.7K
股息收益率
--
每股收益(TTM)
-2.39
市值
$13.7M
什么是 NAII?
Natural Alternatives International, Inc. engages in the manufacturing, distribution, and marketing of nutritional supplements and other health care products. The company is headquartered in Carlsbad, California and currently employs 293 full-time employees. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. The company manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer's preferences. The company also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.